Gastroenterology

Safety of proton pump inhibitors questioned based on a large randomized trial of patients receiving rivaroxaban or aspirin

Safety of proton pump inhibitors questioned based on a large randomized trial of patients receiving rivaroxaban or aspirin

Source link




Related posts

LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival

Newsemia

Nurse-Led Program in Primary Care Can Up Detection of Liver Dz

Newsemia

Kratom’s risk obscured by ‘soft data’

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy